Project Grant R01NS136434

Award Date 12/1/24
Completion Date 11/30/29
Dollars Obligated $609K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Riverside, CA 92521, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research on the role of LRRC8 anion channels in brain taurine signaling and body fluid homeostasis. The $245,938 award, valid from December 1, 2024 to November 30, 2026, will address the critical, but previously unknown, role of volume-regulated anion channels (VRACs) formed by...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $426,250 Project Grant under CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders, to the Regents of the University of Minnesota, Office of Sponsored Projects Administration. This 2-year grant will fund research using cutting-edge voltage imaging to examine how interactions between specific neuronal circuit elements in the hippocampus relate to the development of temporal lobe...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $657,958 to Trustees of Boston University to conduct research on the cellular and network mechanisms of epilepsy and neuromodulation. The research aims to elucidate the neuronal mechanisms underlying epileptic activity, reveal insights on how specific biomarkers relate to...
This federal Project Grant award, in the amount of $376,355, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant will fund research by Albany Medical College to investigate the role of microglial insulin-like growth factor 1 (IGF1) in epileptogenesis, the process by which a normal brain is transformed into an epileptic brain. The research aims to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the role of the SUR1-TRPM4 channel in chronic seizure activity and neuronal hyperexcitability. The $129,454 award, with a period of performance from December 2024 to April 2025, will be used to conduct in vitro and in vivo studies to define how neuronal...
This $143,244.00 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate the impact of SCN8A epileptic encephalopathy (EE) mutations on parvalbumin-positive (PV) inhibitory interneurons. The research aims to characterize how SCN8A mutations affect the intrinsic excitability, voltage-gated sodium currents, and synaptic...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to investigate the non-canonical roles of voltage-gated sodium channels (VGSCs) in neurodevelopmental epilepsy. The $145,642 award to The Trustees of Columbia University will fund a 3-year research project examining the influence of SCN3A gene variants on...
This federal Project Grant award, ID R21NS133670, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $207,387 grant supports research to characterize circuit dysfunction in a mouse model of a genetic epilepsy disorder, with a focus on understanding the role of specific interneuron subtypes in the hippocampus and neocortex. The research team at the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $608,787 to the University of California, San Diego to investigate a novel mechanism for how dysfunctional mitophagy (selective autophagy of mitochondria) contributes to brain ischemia-reperfusion injury. The research aims to determine if inactivation of the...
This federal Project Grant award, valued at $431,676.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The research aims to investigate the molecular mechanisms involving the glucocorticoid receptor, cytochrome P450, and P-glycoprotein axis, and...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to investigate the role of astrocytic volume-regulated anion channels (VRAC) in seizure generation, epileptogenesis, and associated neurological pathologies. The $608,899 award to the Regents of the University of California at Riverside, effective from December 1, 2024 to November 30, 2029, will fund research to: 1) determine how astrocytic VRAC contribute to brain tissue swelling and seizure initiation in vivo, 2) measure the involvement and therapeutic potential of astrocytic VRAC in the development of epilepsy using genetic manipulation techniques, and 3) identify the cellular mechanisms by which VRAC mediate changes in astrocyte volume regulation and neural excitability. The overarching goal is to advance the understanding of cell volume regulation, glutamate release, and glial-neuronal interactions, with the potential to identify novel targets for treating seizure disorders, excitotoxicity, and epilepsy.

Generated 7/1/25, 4:20 AM